Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ Gold
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ Gold
Subscribe
FREE
Edition
European
US
Neurology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Evidence on VNS in the Modern DRE Treatment Landscape
13
Mins
August 2025
Epilepsy affects around 50 million people worldwide. Approximately 30% of them experience drug-resistant epilepsy (DRE), which…
Read more
13
Mins
29 Aug 2025
Evidence on VNS in the Modern DRE Treatment Landscape
Epilepsy affects around 50 million people worldwide. Approximately 30% of them experience drug-resistant epilepsy (DRE), which…
4
Mins
5 Aug 2025
Spotlight on CIDP
Exploration of key data on chronic inflammatory demyelinating polyneuropathy (CIDP) presented at EHA 2025. Post-hoc analysis of the ADHERE…
2
Mins
5 Aug 2025
How Clinicians Can Encourage People with Multiple Sclerosis
Multiple sclerosis (MS) is a complex, lifelong neurological condition that presents with unpredictable symptoms, progressive disability…
15
Mins
5 Aug 2025
Precision Medicine in Neurology: Advancing Care for Female Patients
Historically, sex-related differences have been underexplored in neurology. It is important to highlight the distinction between sex and…
13
Mins
5 Aug 2025
The Intersection of Menopause and Epilepsy
Epilepsy is a serious and common neurological condition, characterised by recurring, unprovoked seizures, affecting approximately 25…
5
Mins
5 Aug 2025
The Versatility of Neurosonology: Vertebrobasilar Pathology
Neurosonology is a versatile, non-invasive diagnostic modality for evaluating cerebral circulatory disorders.1 It provides real-time…
5
Mins
29 Jul 2025
CIDP Through a Patient’s Lens
In this patient-focused interview, EMJ spoke to Jean-Philippe Plançon, a patient with chronic inflammatory demyelinating….
7
Mins
24 Jul 2025
Patient Advocacy in Huntington's: Interview with Astri Arnesen
It all began when my mother was diagnosed with Huntington’s disease. At the time, Huntington’s was a rare disease, and it still is by…
7
Mins
24 Jul 2025
Psychedelics in Psychiatry: Interview with Christina Dalla
EMJ spoke with Christina Dalla, a pioneering researcher in neuropsychopharmacology and expert in sex differences in neuropsychiatric…
3
Mins
17 Jul 2025
Regenerating Neural Function: Interview with Lukas Rasulic
EMJ spoke with Lukas Rasulic to explore the latest advances in peripheral nerve repair, the integration of functional neurosurgery, and…
6
Mins
27 Jun 2025
Critical Management of Neurocysticercosis with Hydrocephalus
Neurocysticercosis, a parasitic brain infection caused by the larvae of Taenia solium that leads to cysts in the central nervous system…
4
Mins
26 Jun 2025
Mitigating the Treatment Gap in Drug-Resistant Epilepsy
For this article, EMJ conducted an interview with Ahmed Abdelmoity, Professor and Director, Division of Neurology, Children’s Mercy…
5
Mins
5 Jun 2025
CAR-T Cell Therapy in MS
CAR T Therapy: The NEX-T Frontier in MS, a BMS non-promotional symposium at ECTRIMS 2024, presents a thought-provoking view on the potential role of CAR-T cell therapy in Multiple Sclerosis. 𝗙𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗣𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀𝗼𝗻𝗹𝘆. 𝗧𝗵𝗶𝘀 𝘀𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝘄𝗮𝘀 𝗼𝗿𝗴𝗮𝗻𝗶𝘀𝗲𝗱 𝗮𝗻𝗱 𝗳𝘂𝗻𝗱𝗲𝗱 𝗯𝘆 𝗕𝗿𝗶𝘀𝘁𝗼𝗹 𝗠𝘆𝗲𝗿𝘀 𝗦𝗾𝘂𝗶𝗯𝗯. 𝗕𝗠𝗦 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗮𝗻𝗱/𝗼𝗿 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗺𝗮𝘆 𝗯𝗲 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗲𝗱. (IMM-GB-2400302) | Date of Prep: June 2025
13
Mins
31 May 2025
Navigating treatment switch in LOPD
This symposium, ‘A case-based approach to navigating treatment switch in late-onset Pompe Disease (LOPD)’, was held at the 21st…
6
Mins
29 May 2025
Blood-Based Neurology Biomarkers
The landscape of neurology biomarkers has evolved significantly in recent years, affording new clinical insights that are helping to…
7
Mins
22 May 2025
FcRn Blockers in gMG A Case-Study
Generalised myasthenia gravis (gMG) is a rare and chronic IgG-mediated autoimmune neuromuscular disease that causes fluctuating and…
5
Mins
21 May 2025
Perampanel as Early Add-On
Leading neurologist discusses evidence from a real-world post hoc analysis of the PERMIT study supporting perampanel as early add-on…
8
Mins
2 May 2025
Clinical Advancements in Becker Muscular Dystrophy
Becker is a serious, progressive muscular dystrophy that presents predominantly in males due to an X-linked…
9
Mins
14 Apr 2025
Intravenous Anti-CGRP Therapy for the Treatment of Migraine
This promotional advertorial article has been fully commissioned by Lundbeck Ltd. UK PI & AER info is available within the article…
7
Mins
13 Mar 2025
New Horizons for Metachromatic Leukodystrophy
This article summarises an Orchard Therapeutic-sponsored symposium titled ‘New horizons for metachromatic leukodystrophy – with the advent…
7
Mins
13 Mar 2025
Does the Gut Microbiome Influence the Efficacy of Psychiatric Drugs?
Altered gut microbiome profiles correlate with anxiety and depression in humans, and work in animal models has identified specific…
5
Mins
13 Mar 2025
Systemic Health Impact of Leaky Barriers in the Oral-Gut-Brain Axis
The human body is a holistic system, interconnected by the circulatory, nervous, lymphatic, endocrine, and immune systems that facilitate…
5
Mins
13 Mar 2025
Infliximab-Induced Multifocal Motor Neuropathy
Multifocal motor neuropathy (MMN) is a rare immune-mediated disorder characterised by progressive, asymmetric muscle weakness…
2
Mins
11 Feb 2025
Targeting Tau in Early Alzheimer’s Disease
Phase 2 randomised controlled trial (RCT) of BMS-986446, a monoclonal antibody targeting the tau microtubule binding region (MTBR)…
5
Mins
24 Jan 2025
Early Intervention in MS
A satellite symposium titled ‘Transforming MS Care: Early Intervention and Sustained Safety’ held at the 40th Congress of the European…
8
Mins
16 Jan 2025
Long-Term Patient Outcomes: The Role of Sustained Treatment Efficacy in Myasthenia Gravis
There have been great advances in the field of generalised myasthenia gravis (gMG) in recent years, but many patients remain dissatisfied…
9
Mins
12 Dec 2024
The CORE-VNS study: Design and Interim Analysis
This article summarises a LivaNova-sponsored symposium entitled ‘The Power of Real-World Evidence with CORE-VNS’, delivered on 7th…
31 Oct 2024
Tackling Infectious Diseases
This interactive article summarises key discussions from GSK sponsored symposia that took place during the ESCMID Global Congress 2024, held from 27–30th April 2024 in Barcelona, Spain.
4 Oct 2024
The Unspeakable Disease: A Tale of Two Siblings
The deficiency of arylsulfatase A due to the mutations in the ARSA gene is the cause of a rare inherited lysosomal storage disease…
11
Mins
12 Sep 2024
Early Recognition, Diagnosis, and Treatment of Friedreich Ataxia
At the 2024 European Association of Neurology (EAN) Congress, one satellite symposium discussed the recognition, diagnosis, and treatment…
6
Mins
27 Aug 2024
Understanding Developmental and Epileptic Encephalopathies
Developmental and epileptic encephalopathy (DEE) refers to a collection of rare and severe epilepsies that feature both seizures and…
8
Mins
13 Aug 2024
Reimagining Myasthenia Gravis Care
Myasthenia gravis (MG) is an autoimmune disease caused by autoantibodies targeting proteins on the neuromuscular junction. Around 85%…
8
Mins
13 Aug 2024
Update on Daridorexant for Insomnia
During this symposium, held at the 10th Congress of the European Academy of Neurology (EAN), speakers highlighted that chronic insomnia…
2
Mins
13 Aug 2024
Nipocalimab and gMG: Top Line Results from the Phase III Vivacity-MG3 Study
Nipocalimab, a high-affinity, fully human, aglycosylated, effectorless, monoclonal antibody, has been developed as an add-on treatment…
5
Mins
13 Aug 2024
Diagnosing Synucleinopathies
Parkinson’s disease (PD) is the second-most common neurodegenerative disease after Alzheimer’s disease (AD), with an estimated…
9
Mins
13 Aug 2024
Patterns of Laryngeal Changes on Clinical Application of Mechanical Insufflation-Exsufflation
Individuals with neuromuscular diseases (NMD), where deterioration in bulbar function coexists with respiratory muscle weakness, are at…
10
Mins
13 Aug 2024
A Rare Case of Cervical Intramedullary Spinal Cord Abscess
The occurrence of intramedullary spinal cord abscesses (ISCA) is rare, a phenomenon attributable to a confluence of physiological and…
5
Mins
13 Aug 2024
Bromocriptine in the Management of Central Hyperthermia
Fever is a common medical issue encountered in neurorehabilitation units. The most common cause of fever is infection; the common…
7
Mins
1 Aug 2024
Interview: Kailash Bhatia
I completed my neurology training in Mumbai, India. At the end of my general medical degree, I was influenced by a top-rate neurologist…
6
Mins
19 Jul 2024
Roundtable Interview: Olivier Rascol and Wassilios Meissner
When I started as a neurologist and a clinical pharmacologist, there were a lot of interesting developments in movement disorders…
9
Mins
13 Jun 2024
Balancing Exercise and Contraction-induced Muscle Injury in Muscular Dystrophies
The rare diseases Duchenne and Becker are X-linked recessive neuromuscular disorders.1 They are characterised by progressive…
8
Mins
19 Mar 2024
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Masterclass Event Summary
A masterclass initiated, organised, and funded by UCB, sought to advance understanding and expertise of myelin oligodendrocyte…
8
Mins
15 Mar 2024
Impact of Non-Seizure Symptoms in Dravet Syndrome and Lennox-Gastaut Syndrome
Non-seizure symptoms in Dravet and Lennox-Gastaut syndromes can affect speech, gait, appetite, mood, development, and sleep and impact…
8
Mins
14 Dec 2023
Spasticity Following Acute Stroke
Many patients experience impairment following a stroke, including motor or cognitive impairment, urinary incontinence, dysphagia…
8
Mins
14 Dec 2023
Tackling Becker Muscular Dystrophy
First described by German physician Peter Emil Becker in the 1950s, Becker is an X-linked genetic recessive disorder. Like Duchenne…
7
Mins
20 Nov 2023
A Review of Oral Fixed-Dose Sodium Phenylbutyrate and Ursodoxicoltaurine in People with Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that is estimated to affect approximately 300,000 individuals worldwide…
11
Mins
4 Oct 2023
Lennox–Gastaut Syndrome: Challenges in Diagnosis – Interviews with Two Key Opinion Leaders
Lennox–Gastaut syndrome (LGS) is a severe childhood-onset epilepsy syndrome that can be challenging to identify due to its heterogeneous and..
13
Mins
14 Sep 2023
The Unspeakable Disease: A Tale of Two Siblings
The deficiency of arylsulfatase A due to the mutations in the ARSA gene is the cause of a rare inherited lysosomal storage disease…
6
Mins
14 Sep 2023
Assessment of Post-Traumatic Stress Disorder in Patients Who Recovered from COVID-19
It is essential to address psychological health, particularly post-traumatic stress disorder (PTSD), among patients who have recovered from…
11
Mins
15 Aug 2023
Focal Onset Seizures: New Treatment Options in The Clinical Practice
Carreño began by discussing the spectrum of uncontrolled epilepsies. They stressed that uncontrolled epilepsy does not necessarily…
15 Aug 2023
Retracted: A Spotlight on Friedreich Ataxia: Optimising the Patient Journey from Diagnosis to Disease Management
This article has now been retracted and a retraction statement has been published.
6
Mins
15 Aug 2023
Development of the Clinical Myotonia Rating Scale and a Mexiletine Prescribing and Monitoring Algorithm for Patients with Non-Dystrophic Myotonia
In the rare neuromuscular disorders classed as NDM, muscle stiffness (myotonia) is the major symptom and is defined by a delayed muscle…
8
Mins
15 Aug 2023
Mitochondrial DNA Maintenance Disorders: Impact of Impaired Deoxynucleoside Triphosphates Metabolism
The maintenance of mitochondrial DNA (mtDNA) is dependent upon several nuclear gene-encoded proteins including enzymes forming the…
4
Mins
15 Aug 2023
Interview: Hugh Selsick
My science degrees were pivotal in fuelling my passions and setting out my career path. During my undergraduate physiology degree…
7
Mins
15 Aug 2023
Cerebrotendinous Xanthomatosis: A Clinical Series Illustrating the Radiological Findings
Cerebrotendinous xanthomatosis (CTX) is a unique disease with an autosomal recessive inheritance, occurring due to the accumulation…
7
Mins
15 Aug 2023
Study for Assessment of Mental Health in Survivors of COVID-19
COVID-19 infection was first reported in December 2019 in Wuhan, China, as a pneumonia outbreak presenting with fever…
Loading posts...
« Previous
1
…
5
6
7
8
9
…
23
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View